Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Novartis team tracks remissions of 4-plus years in a pioneering CAR-T study
Fierce Biotech
Thu, 09/3/15 - 08:40 am
Tags:
Novartis
,
CAR-T
,
CTL019
,
CLL
,
chronic lymphocytic leukemia
Amgen cannot stop imminent sale of Neupogen copycat: US appeals court
Yahoo/Reuters
Wed, 09/2/15 - 12:37 pm
Tags:
Amgen
,
Neupogen
,
biosimilars
,
Zarxio
,
Novartis
,
Sandoz
Novartis to Work With Amgen on Alzheimer’s and Migraine Drugs
Bloomberg
Wed, 09/2/15 - 10:18 am
Tags:
Novartis
,
Amgen
,
migraines
,
Alzheimer's disease
,
R&D
,
CNP520
,
AMG 334
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Tue, 09/1/15 - 06:35 pm
Tags:
Novartis
,
Europe
,
melanoma
,
GSK
,
Mekinist
,
Tafinlar
FDA Grants Expanded Use of Promacta for Novartis
Yahoo/24-7 Wall St
Tue, 08/25/15 - 08:30 am
Tags:
FDA
,
Novartis
,
Promacta
,
chronic immune thrombocytopenia
,
ITP
Novartis snaps up MS indication for Glaxo's Arzerra
BioPharma Dive
Mon, 08/24/15 - 11:38 am
Tags:
Novartis
,
MS
,
multiple sclerosis
,
GSK
,
Arzerra
Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Tags:
Amgen
,
generics
,
biosimilars
,
Novartis
,
Sandoz
,
Neupogen
,
Zarxio
Novartis Declines As Merck Wins Patent Battle
Bidness, ETC
Fri, 08/21/15 - 09:47 am
Tags:
Novartis
,
Emend
,
patents
,
Merck
,
generics
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Fierce Biotech
Fri, 08/21/15 - 09:29 am
Tags:
GSK
,
Novartis
,
MS
,
multiple sclerosis
,
ofatumumab
Big Pharma still a big deal for NJ economy, despite cost cuts
Fierce Pharma
Wed, 08/19/15 - 12:21 pm
Tags:
Big Pharma
,
New Jersey
,
JNJ
,
Merck
,
Novartis
,
Bristol-Myers Squibb
,
Sanofi
,
Bayer
,
Roche
GlaxoSmithKline Deal Unlikely To Help Novartis AG Top Oncology Sales
Bidness, ETC
Mon, 08/17/15 - 11:11 am
Tags:
GSK
,
Novartis
,
Roche
,
oncology
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
Tags:
AbbVie
,
Amgen
,
biosimilars
,
JNJ
,
Sandoz
,
Novartis
,
Humira
,
Neupogen
,
Remicade
,
Nuelasta
,
Enbrel
,
epoetin-alfa
GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain
Bidness, ETC
Mon, 08/10/15 - 11:23 am
Tags:
GSK
,
Pfizer
,
M&A
,
Novartis
,
Roche
Glaxo’s Best ‘Headache’ Remedy May Be Buying Stakes in Ventures
Bloomberg
Fri, 08/7/15 - 08:44 am
Tags:
GSK
,
Advair
,
Pfizer
,
Shionogi
,
Novartis
FDA updates label for Novartis' MS pill Gilenya after reports of brain infection
Fierce Pharma
Wed, 08/5/15 - 02:46 pm
Tags:
FDA
,
Novartis
,
Gilenya
,
MS
,
multiple sclerosis
Will Biogen Win From Novartis MS Drug Safety Label Change?
Yahoo/24 7 Wall St
Tue, 08/4/15 - 06:54 pm
Tags:
Biogen
,
Novartis
,
MS
,
multiple sclerosis
,
Gilenya
Why Sandoz Revenues Were Important for Novartis in 2Q15
Yahoo/Market Realist
Wed, 07/29/15 - 12:43 pm
Tags:
Novartis
,
Sandoz
,
generics
,
earnings
Novartis swaps mid-stage compounds for equity stake in start-up Mereo BioPharma
First Word Pharma
Wed, 07/29/15 - 12:42 pm
Tags:
Novartis
,
Mereo BioPharma
Sandoz closing three German and Indian factories
BioPharma Dive
Tue, 07/28/15 - 10:14 am
Tags:
Sandoz
,
Novartis
,
generics
,
Germany
,
India
Analyst: J&J's Stelara to challenge Novartis in ankylosing spondylitis
Fierce Pharma
Tue, 07/28/15 - 12:36 am
Tags:
JNJ
,
Stelara
,
Novartis
,
ankylosing spondylitis
Pages
« first
‹ previous
…
84
85
86
87
88
89
90
91
92
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.